November 6, 2024. More for You ...

This outcome stemmed from effective cost management strategies and revenue growth initiatives. The company reported a 14% increase in net sales to $1.9 billion, demonstrating significant year-over ...

The leaders of Xcel Energy Inc. have raised their electric sales growth forecast for the next five years to 5% on average but expect that data center operators and oil and gas firms in Texas could ...

Net sales reached $1,255 million, a 31.3% increase from the prior year, exceeding management's anticipated growth of 25% to 28%. Non-GAAP diluted EPS of $3.49 exceeded management's guidance range ...

Sales for retailers and eateries grew by 0.4% in September from a month earlier, according to advance data from the Census Bureau, an acceleration from 0.1% growth in August and a higher pace than ...

Semiconductor sales growth will ease globally in 2025, research firm Gartner said on Monday. It predicted that growth in semiconductor sales will jump 18.8% in 2024 to $629.8 billion but 13.8% in ...

New artificial intelligence-based product offerings could provide further growth opportunities in the future. Leading market share in sales management automation, a market that has significant ...

The National Retail Federation said on Tuesday that it expected holiday sales to increase 2.5 to 3.5 percent from last year, to as much as $989 billion. That’s slightly slower growth than the ...

Data continues to show sales have slumped in the sector after a period of solid growth. Celsius has been further hit by confusing sales data from major distribution partner PepsiCo. (PEP).

Procter & Gamble Co. posted a second straight quarter of sluggish sales growth, dragged down by minimal price increases and weakness in key areas such as skin and baby care. Organic sales ...

Nestlé has cut its forecast for organic sales for the second time this year as consumer demand remains "soft" in still-high food inflation. Presenting nine-month sales figures today (17 October ...

The company also cited sales growth from several other drugs, as total revenue climbed 31% to $17.7 billion in the recently completed quarter. Adjusted earnings totaled $1.06 per share.